Dclk1 labels quiescent pancreatic progenitor and cancer initiating cells

被引：1
|
作者：
Westphalen, Christoph Benedikt [1 ]
Quante, Michael [2 ]
Worthley, Daniel [1 ]
Asfaha, Samuel [1 ]
Remotti, Helen [1 ]
Olive, Kenneth P. [1 ]
Wang, Timothy C. [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Tech Univ Munich, D-80290 Munich, Germany
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5220
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells
    Li, Lianna
    Mei, Hao
    Commey, Abednego Nii Adom
    CANCER GENE THERAPY, 2020, 27 (09) : 691 - 701
  • [42] The effects of DCLK1 isoform 2 upon the migration and invasion capabilities of colorectal cancer cells
    Brown, Valeria
    Li, Lianna
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [43] Long-lived Dclk1+cells serve as colon cancer initiating cells
    Asfaha, Samuel
    Westphalen, Christoph Benedikt
    Hayakawa, Yoku
    Takemoto, Yoshihiro
    Lukin, Dana J.
    Setlik, Wanda
    Remotti, Helen
    Muley, Ashlesha
    Chen, Xiaowei
    May, Randal
    Houchen, Courtney W.
    Fox, James G.
    Gershon, Michael D.
    Quante, Michael
    Wang, Timothy
    CANCER RESEARCH, 2014, 74 (19)
  • [44] DCLK1 might be a therapeutic target of osthole against cervical cancer
    Pan, Liuliu
    Zhang, Xiaodan
    Wang, Danhan
    Huang, M. I. N.
    Huang, Qiusui
    Duan, Ping
    Mei, Jie
    PHARMAZIE, 2021, 76 (10): : 503 - 506
  • [45] Design, synthesis and biological evaluation of novel DCLK1 inhibitor containing purine skeleton for the treatment of pancreatic cancer
    Chen, Yuepeng
    Meng, Liuqiong
    Wang, Wenze
    Ye, Liu
    Huang, Lei
    Wang, Chenghao
    Wang, Shuping
    Li, Mengyao
    Pei, Yingxin
    Zhang, Shijie
    Zou, Yi
    Xu, Yungen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 261
  • [46] Dclk1 distinguishes between tumor and normal stem cells in the intestine
    Nakanishi, Yuki
    Seno, Hiroshi
    Fukuoka, Ayumi
    Ueo, Taro
    Yamaga, Yuichi
    Maruno, Takahisa
    Nakanishi, Naoko
    Kanda, Keitaro
    Komekado, Hideyuki
    Kawada, Mayumi
    Isomura, Akihiro
    Kawada, Kenji
    Sakai, Yoshiharu
    Yanagita, Motoko
    Kageyama, Ryoichiro
    Kawaguchi, Yoshiya
    Taketo, Makoto M.
    Yonehara, Shin
    Chiba, Tsutomu
    NATURE GENETICS, 2013, 45 (01) : 98 - U143
  • [47] Dclk1 distinguishes between tumor and normal stem cells in the intestine
    Yuki Nakanishi
    Hiroshi Seno
    Ayumi Fukuoka
    Taro Ueo
    Yuichi Yamaga
    Takahisa Maruno
    Naoko Nakanishi
    Keitaro Kanda
    Hideyuki Komekado
    Mayumi Kawada
    Akihiro Isomura
    Kenji Kawada
    Yoshiharu Sakai
    Motoko Yanagita
    Ryoichiro Kageyama
    Yoshiya Kawaguchi
    Makoto M Taketo
    Shin Yonehara
    Tsutomu Chiba
    Nature Genetics, 2013, 45 : 98 - 103
  • [48] miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1
    Sakaguchi, Masazumi
    Hisamori, Shigeo
    Oshima, Nobu
    Sato, Fumiaki
    Shimono, Yohei
    Sakai, Yoshiharu
    MOLECULAR CANCER RESEARCH, 2016, 14 (04) : 354 - 362
  • [49] DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer
    Tianbo Gao
    Min Wang
    Lingling Xu
    Tao Wen
    Jian Liu
    Guangyu An
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 2131 - 2140
  • [50] DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer
    Gao, Tianbo
    Wang, Min
    Xu, Lingling
    Wen, Tao
    Liu, Jian
    An, Guangyu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (10) : 2131 - 2140
12345